Devonian Health Group Inc.
GSD.V
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 256.11% | 344.33% | 727.46% | 1,159.94% | 419.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 256.11% | 344.33% | 727.46% | 1,159.94% | 419.32% |
| Cost of Revenue | 293.10% | 444.86% | 823.04% | 1,356.48% | 364.32% |
| Gross Profit | 190.98% | 220.34% | 606.57% | 788.82% | 556.18% |
| SG&A Expenses | 0.71% | 134.82% | 77.31% | 12.30% | 119.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1.31% | 1.31% | 1.87% | 4.27% | 4.09% |
| Total Operating Expenses | 133.18% | 230.90% | 312.65% | 192.93% | 141.88% |
| Operating Income | 120.18% | 11.66% | 248.06% | 80.23% | -15.14% |
| Income Before Tax | 116.43% | 16.37% | 221.99% | 74.89% | -14.66% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 82.12% | 16.37% | 221.99% | 74.89% | -14.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 82.12% | 16.37% | 221.99% | 74.89% | -14.66% |
| EBIT | 120.18% | 11.66% | 248.06% | 80.23% | -15.14% |
| EBITDA | 130.47% | 10.65% | 307.87% | 86.67% | -17.02% |
| EPS Basic | 81.97% | 16.67% | 220.45% | 77.11% | -3.39% |
| Normalized Basic EPS | 115.79% | 17.39% | 222.22% | 76.92% | -2.70% |
| EPS Diluted | 85.14% | 18.92% | 220.45% | 77.11% | 0.00% |
| Normalized Diluted EPS | 115.79% | 17.39% | 222.22% | 76.92% | -2.70% |
| Average Basic Shares Outstanding | 1.28% | 1.55% | 0.57% | 11.48% | 10.62% |
| Average Diluted Shares Outstanding | 1.28% | 1.55% | 0.57% | 11.48% | 10.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |